?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
September 20, 2021
signalgroup
Senator Wyden, fulfill your promise to lower drug costs for Oregonians by increasing access to next generation generics known as biosimilars
News
September 20, 2021
signalgroup
Senator Carper, fulfill your promise to lower drug costs for Delawareans by increasing access to next generation generics known as biosimilars
News
September 9, 2021
signalgroup
Biden Administration’s Plan to Lower Prescription Drug Prices Supports Biosimilar Competition, which will Decrease Drug Costs
News
August 12, 2021
signalgroup
President Biden’s Plan to Lower Drug Prices Highlights Need for Competition from Biosimilars
News
August 11, 2021
signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Organon
News
July 29, 2021
signalgroup
FDA’s Approval of First Interchangeable Biosimilar Product Paves Way for Lower Health Care Costs for Patients
News
July 15, 2021
signalgroup
Food & Drug Administration Takes Strong Enforcement Action Against Biosimilar Misinformation
News
July 9, 2021
signalgroup
President Biden’s Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients
News
July 8, 2021
signalgroup
Morning Consult: Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate
News
June 30, 2021
signalgroup
Biosimilars Forum Member Spotlight: 6 Questions for Coherus
Prev page
04
05
06
07
08
Next page